IL17A and chronic obstructive pulmonary disease: KEGG analysis showed that the relevant YQJPR signaling pathways in the treatment of COPD included virus infection, TNF, IL-17, HIF-1, MAPK, AGE-RAGE, and cancer pathways (Supplementary Table 3).